Yusop, Mia .
HRN: 15-52-20 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2023
CEFTRIAXONE 1G (VIAL)
10/18/2023
10/25/2023
IV
2g
OD
UTI
Checking Final Appropriateness
10/18/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/18/2023
10/25/2023
IV
600mg
Q6hr
Nonhealing Wound
Checking Final Appropriateness
10/25/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/25/2023
11/01/2023
IV
600mg
Q8
Infected Wound
Checking Final Appropriateness